Cell-to-cell fusion can be quantified by endowing acceptor and donor cells with latent reporter genes/proteins and activators of these genes/proteins, respectively. One way to accomplish this goal is by using a bipartite lentivirus vector (LV)-based cell fusion assay system in which the cellular fusion partners are transduced with a flippase-activatable Photinus pyralis luciferase (PpLuc) expression unit (acceptor cells) or with a recombinant gene encoding FLPe NLS+ , a nuclear-targeted and molecularly evolved version of flippase (donor cells). Fusion of both cell populations will lead to the FLPe-dependent generation of a functional PpLuc gene. PpLuc activity is typically measured in cell lysates, precluding consecutive analysis of one cell culture. Therefore, in this study the PpLuc-coding sequence was replaced by that of Gaussia princeps luciferase (GpLuc), a secretory protein allowing repeated analysis of the same cell culture. In myotubes the spread of FLPe NLS+ may be limited due to its nuclear localization signal (NLS) causing low signal outputs. To test this hypothesis, myoblasts were transduced with LVs encoding either FLPe NLS+ or an NLS-less version of FLPe (FLPe NLS2 ) and subsequently co-cultured in different ratios with myoblasts containing the FLPe-activatable GpLuc expression cassette. At different times after induction of cell-to-cell fusion the GpLuc activity in the culture medium was determined. FLPe NLS+ and FLPe NLS2 both activated the latent GpLuc gene but when the percentage of FLPe-expressing myoblasts was limiting, FLPe NLS+ generally yielded slightly higher signals than FLPe NLS2 while at low acceptor-to-donor cell ratios FLPe NLS2 was usually superior. The ability of FLPe NLS+ to spread through myofibers and to induce reporter gene expression is thus not limited by its NLS. However, at high FLPe concentrations the presence of the NLS negatively affected reporter gene expression. In summary, a rapid and simple chemiluminescence assay for quantifying cell-to-cell fusion progression based on GpLuc has been developed.
Introduction
During cell-to-cell fusion, plasma membranes of individual cells merge to form a multinucleated structure called a syncytium. Plasma membrane fusion is a crucial event during, for example, fertilization, syncytiotrophoblast production, skeletal muscle formation, bone remodeling, eye lens development and certain forms of tissue repair [1] . In general, cell fusion is a tightly regulated and highly selective process involving specific cell types. Inappropriate cell fusion has been implicated in tumor development and progression [2] .
Cell fusion can be easily observed using microscopic techniques and in many studies the extent of cell fusion is expressed as fusion index, which either stands for the percentage of cells with two or more nuclei or the percentage of nuclei present in syncytia [3] . However, without continuous monitoring, it is impossible to decide by microscopy alone whether multinucleation is caused by cell fusion or the result of karyokinesis without cytokinesis. In addition, cells growing on top of each other can be mistaken for syncytia. Furthermore, as fusion index determinations are generally carried out manually, they are laborious, error-prone and often inaccurate. This has led to the development of methods for quantifying cell fusion independent of microscopic inspection.
Nearly all these methods are based on systems of two components that interact to create a novel detectable signal only after cell fusion [3] . Mohler and Blau, for example, developed a quantitative cell fusion assay based on functional complementation between two biologically inactive b-galactosidase deletion mutants [4] . Another possibility to produce fusion-dependent signals is by applying site-specific recombination systems such as Cre-loxP and FLP-FRT. In these systems, a latent reporter gene is activated by the action of the site-specific DNA recombinase Cre from bacteriophage P1 or flippase/FLP from Saccharomyces cerevisiae, which catalyze the excision and inversion of DNA flanked by 34-base pair (bp) recognition sequences (loxP for Cre and FRT for FLP) in a direct or inverted repeat configuration, respectively [5, 6] .
Gonçalves et al. previously developed a bipartite lentivirus vector (LV)-based cell fusion assay system in which the cellular fusion partners are endowed with a FLP-activatable Photinus pyralis luciferase (PpLuc) expression unit/''gene switch'' (acceptor cells) or with a recombinant gene encoding a molecularly evolved version of FLP (FLPe) with a nuclear localization signal (NLS) derived from the simian virus 40 large T antigen (donor cells) [7] . Fusion between acceptor and donor cells led to the FLPe-dependent generation of a functional episomal PpLuc expression module. This cell fusion monitoring system was successfully used to study the role of the p38 MAPK signaling pathway in myoblast fusion/ myotube formation. However, since PpLuc is a cytoplasmic protein and its substrate D-luciferin is poorly membrane-permeable, this assay requires lysis of the cells prior to luminometry and does not allow repeated analysis of the same cell culture. This prompted us to develop a nondestructive method to quantify cell fusion using the bipartite LV-based cell fusion assay system described by Gonçalves and colleagues as starting point.
The key difference between the new and ''old'' version of the LV-based cell fusion assay system is the replacement of the PpLuc open reading frame (ORF) in the ''original'' gene switch construct by the humanized coding sequence of Gaussia princeps luciferase (GpLuc), which is a secretory protein converting the substrate coelenterazine into coelenteramide plus light. GpLuc also displays a much higher specific luciferase activity than PpLuc and is exceptionally resistant to exposure to heat and strongly acidic and basic conditions [8] . In addition, we hypothesized that in myotubes the spread of nuclear-targeted FLPe (FLPe NLS+ ) beyond the direct surroundings of donor nuclei may be limited due to the presence of the NLS. This would result in the activation of only a fraction of the reporter genes especially in hybrid myotubes containing a relatively low percentage of FLPe gene-positive donor nuclei compared to GpLuc-encoding acceptor nuclei. To test this hypothesis, we generated an LV encoding an NLS-less version of FLPe (FLPe NLS2 ) and compared, in myogenic fusion assays, its ability to activate latent GpLuc genes with that of FLPe NLS+ .
Materials and Methods

Plasmids
DNA constructions were carried out with enzymes from Fermentas (Fisher Scientific, Landsmeer, the Netherlands) or from New England Biolabs (Bioké, Leiden, the Netherlands) by using established procedures [9] or following the instructions provided with specific reagents.
To generate a bicistronic self-inactivating (SIN) human immunodeficiency virus type 1 (HIV1) vector shuttle plasmid coding for Streptomyces alboniger puromycin N-acetyl transferase (PurR) and FLPe NLS2 , pLV.FLPe.PurR ( [7] ; GenBank accession number: GU253314; hereinafter referred to as pLV.hCMV-IE.FLPe NL-S+ .IRES.PurR.hHBVPRE; Fig. 1A ) was digested with BshT1 and Eco81I and the 9.6-kb DNA fragment containing the vector backbone was purified from agarose gel. The hybridization product of oligodeoxyribonucleotides 59 CCGGTACCATGAGT-CAATTTGATATATTATGTAAAACACCACC 39 and 59 TTAGGTGGTGTTTTACATAATATATCAAATTGACT-CATGGTA 39 (both from Eurofins MWG Operon, Ebersberg, Germany) was combined with the 9.6-kb BshT16Eco81I fragment of pLV.hCMV-IE.FLPe NLS+ .IRES.PurR.hHBVPRE by ligation with bacteriophage T4 DNA ligase producing pLV.hCMV-IE.FLPe NLS2 .IRES.PurR.hHBVPRE (Fig. 1B ). To generate a SIN-LV shuttle plasmid carrying a silent GpLuc gene that can be activated by FLP, cloning vector pR6K.MCS was digested with XmaJI and NotI, the 2.2-kb DNA fragment containing the vector backbone was purified from agarose gel and combined with the 0.6-kb GpLuc-encoding XmaJI6NotI fragment of phGluc.dBamHI yielding construct pR6K.GpLuc. The cloning vector pR6K.MCS was derived from construct pA1.GFP.A2 ( [10] ; GenBank accession number: GQ380658) by combining its 2.0-kb SalI6Aflll fragment with the 0.3-kb SalI6Aflll fragment of pMOLUC ( [11] ; Addgene, Cambridge, MA; plasmid number: 12514). Plasmid phGluc.dBamHI was made from the mammalian expression vector phGluc ( [12] ; Addgene; plasmid number: 22522) by self-ligation of its 2.9-kb BamHI fragment. The GpLuc ORF was excised from pR6K.GpLuc by digestion with XmaJI and MluI and combined with the 7.2-kb BcuI6MluI fragment of pLV.GS.DsRed.dKpnI to generate pLV.GS.GpLuc.v1 (Fig. 1D) . The LV shuttle plasmid pLV.GS.DsRed.dKpnI was derived from pLV.pA+.GS.DsRed ( [7] ; GenBank accession number: GU253312) by self-ligation of its 7.9-kb KpnI fragment. The SIN-LV shuttle plasmid pLV.GS.GpLuc.v6 is a derivative of construct pLV.pA+.GS.Luc ( [7] , hereinafter referred to as pLV.GS.PpLuc), in which the sequences interspersed between the rabbit b-hemoglobin gene polyadenylation signal (rHBB pA) and the mouse metallothionein 1 gene (mMT1) pA (i.e. the PpLuc ORF and an FRT sequence) are replaced by a synthetic DNA fragment comprising the GpLuc ORF and an FRT sequence. More details about the genetic makeup of pLV.GS.GpLuc.v1, pLV.GS.GpLuc.v6 and pLV.GS.PpLuc and about the nucleotide sequences located in between the mMT1 pA and Luc ORFs of these three SIN-LV plasmids are provided in Figs. 2 and 3 .
The ligation mixtures were introduced in chemocompetent cells of Escherichia coli strain GeneHogs (Life Technologies Europe, Bleiswijk, the Netherlands) or GT115 (InvivoGen, San Diego, CA). Large-scale plasmid purifications were performed using JETSTAR 2.0 Plasmid Maxiprep kits (Genomed, Löhne, Germany) according to the manufacturer's instructions.
Cells
The culture and differentiation conditions of the murine Bmi1-and human TERT-immortalized human myoblasts (iDMD myoblasts) have been described previously [13] . Fig. 1C ), pLV.GS.GpLuc.v1, pLV.GS.PpLuc and pLV.GS.GpLuc.v6, respectively. The 293T cells were transfected with one of the LV shuttle constructs and the packaging plasmids psPAX2 (Addgene; plasmid number: 12260) and pLP/VSVG (Life Technologies Europe) at a molar ratio of 2:1:1. To concentrate and purify the LV particles, producer cell supernatants were layered onto 5-ml cushions of 20% (wt/vol) sucrose in phosphate-buffered saline (PBS) and centrifuged at 15,000 rotations per minute for 2 h at 4uC in an SW32 rotor (Beckman Coulter Nederland, Woerden, the Netherlands). Prior to ultracentifugation, producer cell supernatants were clarified by low speed centrifugation and filtration through 0.45-mm pore-sized cellulose acetate filters (Pall Netherlands, Mijdrecht, the Netherlands). For more details about the SIN-LV production method, see [15] . The titers of the resulting LV stocks were determined using the RETROTEK HIV-1 p24 Antigen ELISA kit (ZeptoMetrix, Franklin, MA) following the instructions provided by the manufacturer. To derive functional titers from these measurements a conversion factor of 2.5 transducing units (TUs) per pg of HIV-1 p24 protein was used.
Viral vectors
Cell transductions
Cryopreserved LV.FLPe NLS+ .PurR-transduced iDMD myoblasts ( [7] ; hereinafter referred to as myoblasts-FLPe NLS+ ) were thawed and cultured in the presence of puromycin (Life Technologies Europe) at a final concentration of 0.4 mg/ml to prevent transgene silencing. FLPe NLS-expressing iDMD myoblasts were generated by overnight (620 h) exposure of 10 5 cells in a well of a 24-well cell culture plate (Greiner Bio-One, Alphen aan den Rijn, the Netherlands) to 30 TUs of LV.FLPe NLS2 .PurR per cell in 500 ml of growth medium in a humidified atmosphere of 5% CO 2 /95% air at 37uC. The next day, the cell monolayer was rinsed three times with 1 ml of PBS after which fresh culture medium was added. At 3 days post transduction, the culture of LV.FLPe NLS2 .PurR-treated cells (hereinafter referred to as myoblasts-FLPe NLS2 ) as well as a control culture of untransduced iDMD myoblasts were given medium containing 0.8 mg/ml of puromycin. Within a week, all cells in the culture of untransduced iDMD myoblasts had died while the cells in the LV.FLPe NL-S2 .PurR-treated culture were nicely expanding. The myoblastsFLPe NLS2 were passaged once a week (split ratio 1:3) in growth medium containing 0.4 mg/ml of puromycin. Myoblasts GS.GLuc , myoblasts GS.PLuc and myoblasts GS.GLuc+ were generated likewise by exposure of iDMD myoblasts to LV.GS.GpLuc.v1, LV.GS.PpLuc and LV.GS.GpLuc.v6, respectively. Before being used for co-culture experiments, the cells were passaged at least three times to rule out secondary transduction of the FLPeexpressing myoblasts in the co-cultures with luciferase-encoding SIN-LVs [16] .
Co-culture establishment and maintenance
Co-cultures containing a total number of 2610 5 cells were established in wells of 24-well culture plates by mixing myoblastsFLPe NLS+ or myoblasts-FLPe NLS2 with myoblasts GS.GLuc at the indicated ratios. Following an incubation period of about 72 h when the cell monolayers had reached 90-100% confluency, the growth medium was substituted by 400 ml of either differentiation medium or fresh growth medium. At specified time points thereafter, the culture medium (400 ml) was collected and stored at 280uC for luciferase assay. The co-cultures were then either terminated or further incubated at 37uC in a water-saturated atmosphere of 5% CO 2 /95% air. To compare the performance of the newly developed LV.GS.GpLuc.v1-based cell fusion assay system with that of the previously described LV.GS.PpLuc-based cell fusion quantification method [7] , myoblasts GS.GLuc or myoblasts GS.PLuc were cocultured with myoblasts-FLPe NLS+ in different ratios in 24-well culture plates containing 2610 5 cells per well. Samples (culture fluid for cultures containing myoblasts GS.GLuc and cell lysates for cultures containing myoblasts GS.PLuc ) were harvested 96 h and 120 h after induction of myogenic differentiation. Exactly the same approach was used to compare the LV.GS.GpLuc.v1-and LV.GS.GpLuc.v6-based cell fusion assays.
Immunocytology
At different time points after the initiation of differentiation, 1:1 co-cultures of myoblasts-FLPe NLS2 and myoblasts GS.GLuc were fixed by incubation for 30 minutes at room temperature (RT) in PBS containing 4% formaldehyde. To permeabilize the cells, they were exposed for 10 minutes at RT to 0.1% Triton X-100 in PBS. Next, cells were incubated overnight at 4uC with mouse antiskeletal muscle troponin I (skTnI) primary antibody (HyTest, Turku, Finland; clone 12F10) diluted 1:100 in PBS +0.1% donkey serum (Santa Cruz Biotechnology, Santa Cruz, CA) followed by a 2-h incubation at RT with Alexa Fluor 568-conjugated donkey anti-mouse IgG (H+L) secondary antibody (Life Technologies Europe) diluted 1:400 in PBS +0.1% donkey serum. Counterstaining of nuclei was performed with 10 mg/ml Hoechst 33342 (Life Technologies Europe) in PBS. Cells were washed three times with PBS after fixation, permeabilization and incubation with primary antibody, secondary antibody and DNA-binding fluorochrome. To minimize photobleaching, coverslips were mounted in Vectashield mounting medium (Vector Laboratories, Burlingame, CA). Pictures were taken with a fluorescence microscope equipped with a digital color camera (Nikon Eclipse 80i; Nikon Instruments Europe, Amstelveen, the Netherlands) using NIS Elements software (Nikon Instruments Europe).
Subcellular fractionation and western blotting
Myoblasts-FLPe NLS+ and myoblasts-FLPe NLS2 were cultured separately in 24-well cell culture plates at a density of 2610 5 cells per well. Following an incubation period of 72 h when the cell monolayers had reached 90-100% confluency, the growth medium was substituted by 400 ml of either differentiation medium or fresh growth medium. Ninety-six h later, cell fractionation was carried out as described by Suzuki et al. [17] with the following modifications. Cell pellets were suspended in 97.5 ml of ice-cold 0.1% NP40 in PBS. One-third of the lysate was removed as ''whole cell lysate'' and mixed with 5 ml of 106 NuPAGE Sample Reducing Agent and 12.5 ml of 46 NuPAGE LDS Sample Buffer (both from Life Technologies Europe). The rest of the lysate was briefly centrifuged at 4uC after which 32.5 ml GS.GpLuc.v1 (A), pLV.GS.GpLuc.v6 (B) and pLV.GS.PpLuc (C) starting at the HIV1 39 LTR. U5, HIV1 LTR unique 59 region; R, HIV1 LTR repeat region; DU3, enhancer-and promoterless HIV1 LTR unique 39 region; blue arrow, mouse metallothionein 1 gene polyadenylation signal (mMT1 pA); small black triangle, AATAAA motif in mMT1 pA; red diamonds, stop codons in frame with Luc ORFs; large black triangle, minimal FRT sequence; light yellow arrow, GpLuc ORF; green box, 59 in-frame extension of the GpLuc ORF; white arrows, out-of-frame ORFs preceding Luc ORFs; red arrows, inframe ORFs preceding Luc ORFs; dark yellow arrow, PpLuc ORF. doi:10.1371/journal.pone.0102433.g002
of the supernatant was removed as ''cytosolic fraction'' and supplemented with 5 ml of 106NuPAGE Sample Reducing Agent and 12.5 ml of 46 NuPAGE LDS Sample Buffer. The remaining supernatant was removed and the pellet was washed with and suspended in 30 ml PBS, after which 5 ml of 106 NuPAGE Sample Reducing Agent and 12.5 ml of 46NuPAGE LDS Sample Buffer were added to produce the ''nuclear fraction''. Nuclear fractions and whole cell lysates were sonicated for 2 times 10 seconds at 200 Hz using a Soniprep 150 ultrasonic disintegrator (Measuring and Scientific Equipment, London, United Kingdom). After incubating the samples for 1 minute at 100uC, 10 ml of whole cell lysate, 10 ml of cytosolic fraction and 5 ml of nuclear fraction were applied to a NuPAGE Novex 12% Bis-Tris gel (Life Technologies Europe). Following electrophoretic separation, the proteins were transferred to a polyvinylidene difluoride membrane (Amersham Hybond P; GE Healthcare Europe, Diegem, Belgium) by wet electroblotting. Next, the membrane was incubated with 2% ECL AdvanceTM blocking agent (GE Healthcare Europe) in PBS-0.1% Tween 20 (PBST) for 1 h at RT and probed with rabbit anti-FLP (1:200; Diagenode, Seraing, Belgium; CS-169-100), mouse anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:10,000; Merck Millipore, Billerica, MA; clone 6C5) or rabbit anti-lamin A/C (1:10,000; Santa Cruz Biotechnology; sc-20681) primary antibodies overnight at 4uC, followed by a 1-h incubation with appropriate horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology). GAPDH served as cytoplasmic marker protein and lamin A/C antibody was used as nuclear marker protein. Target protein signals were visualized using the SuperSignal West Femto Maximum Sensitivity Substrate Kit (Thermo Scientific, Rockford, IL) and chemiluminescence was measured with the ChemiDoc XRS imaging system (Bio-Rad Laboratories, Veenendaal, the Netherlands). GS.GLuc were seeded in a 24-well cell culture plate at a density of 10 5 cells per well and exposed for 20 h to 75 ml per well of concentrated vector stock diluted in growth medium to a final volume of 500 ml. Next, the cell monolayers were rinsed three times with 1 ml of PBS after which 400 ml fresh growth medium was added. At 24 h after the removal of the inoculum, the culture medium was collected and transiently stored at 280uC for subsequent analysis of luciferase activity. The cells were overlaid with 400 ml of fresh growth medium, which was harvested 24 h later for storage at 280uC until luciferase activity measurement.
FLPe functionality test
Luciferase assay
After thawing the GpLuc-containing samples on ice, 50 ml of each sample was transferred to a well of a white opaque 96-well flat-bottom microtiter plate (OptiPlate-96; PerkinElmer, Groningen, the Netherlands) for chemiluminescence measurements. The native coelenterazine (Promega Benelux, Leiden, the Netherlands) stock solution (5 mg/ml in acidified methanol) was diluted 1,000 times in phenol red-free Dulbecco's modified Eagle's medium (Life Technologies Europe) and equilibrated for 1 h in the dark at RT before starting the measurements. The luciferase activity was measured at RT with the aid of a Wallace 1420 VICTOR 3 multilabel plate reader with automatic injection system (PerkinElmer). Immediately after automated addition of 20 ml of substrate to a well, substrate and sample were mixed by shaking for 1 second (double orbital, 0.1 mm, normal speed). PpLuc activity was measured in cell lysates as previously described [7] . For each condition, three independent samples were measured in three series of measurements.
Statistical analysis
Different experimental groups were compared using the independent samples t-test. Differences among means were considered significant at P#0.05. Graphs were prepared in GraphPad Prism version 5 (GraphPad Software, La Jolla, CA).
Results
Microscopic analysis of cell fusion kinetics
Cultured myoblasts can be prompted to fuse with each other by withdrawing mitogens from the culture medium. This causes a time-dependent accumulation of nuclei in syncytial structures called myotubes or myosacs depending on whether these structures are elongated or rounded. To get a first impression of the cell-to-cell fusion kinetics of the genetically modified iDMD myoblasts, 1:1 co-cultures of myoblasts-FLPe NLS2 and myoblasts GS.GLuc were exposed to myogenic differentiation conditions. As shown in the upper panel of Fig. 4 , the myoblasts started to fuse 48 h after serum withdrawal resulting in the formation of myotubes/sacs. Both the percentage of nuclei present in myotubes/sacs as well as the size of the syncytia increased with time until 120 h following serum removal, after which the cells started to detach from the surface of the culture plates. The fusion process was accompanied by the accumulation of sarcomeric proteins as evinced by the results of the skTnI-specific immunostaining depicted in the lower panel of Fig. 4 .
Immunodetection of FLPe in LV.FLPe NLS+/2 .PurRtransduced iDMD myoblasts
To compare FLPe protein level and intracellular distribution between myoblasts-FLPe NLS+ and myoblasts-FLPe NLS2 , western blot analysis was performed on whole cell lysates as well as on nuclear and cytosolic cell fractions (Fig. 5A) GS.GLuc exposed to growth or differentiation medium and co-cultures of FLPe-expressing myoblasts and myoblasts GS.-GLuc maintained in growth medium served as negative controls. Based on the results of the microscopic analysis of cell fusion activity (Fig. 4) , the culture medium was harvested 96 h after induction of myogenic differentiation. It should be noted, however, that the kinetics of cell fusion progression slightly differed between individual experiments probably reflecting small differences in the myoblast populations used for different experiments. Luciferase activity in the medium of the fusogenic cell cultures depended on the ratio of myoblasts GS.GLuc and myoblasts-FLPe, showed a similar trend for myoblasts-FLPe NLS+ -and myoblasts-FLPe NLScontaining co-cultures and was highest when co-cultures contained 50-95% myoblasts GS.GLuc (Fig. 7A) . The peak of GpLuc activity was reached at myoblast GS.GLuc :myoblast-FLPe ratios of 90:10 and 75:25 for myoblasts-FLPe NLS+ and myoblasts-FLPe NLS2 , respectively (Fig. 7A) . Interestingly, at low myoblast GS.GLuc :myoblast-FLPe ratios (i.e. 10:90 and 5:95) the luciferase activity was significantly higher for myoblasts-FLPe NLS2 than for myoblasts-FLPe NLS+ (Fig. 7A) . Myoblast cultures kept under growth conditions and myoblast-FLPe monocultures maintained in differentiation medium yielded luminescence signals close to or at background levels. The monocultures of myoblasts GS.GLuc did, however, secrete detectable amounts of GpLuc under differentiation conditions although the signal intensity was much lower than that produced by serum-deprived co-cultures containing 50-90% myoblasts GS.GLuc . For the co-cultures containing 50-90% myoblasts GS.GLuc shifting from growth to differentiation medium resulted in a .100-fold increase in luciferase activity (Fig. 7B) .
Use of the LV.FLPe
.PurR/LV.GS.GpLuc-based cell fusion assay system to analyse cell fusion progression
To investigate the utility of the LV.FLPe NLS+/2 .PurR/ LV.GS.GpLuc-based cell fusion assay system to follow cell fusion progression, myoblasts GS.GLuc were mixed with myoblastsFLPe NLS+ or with myoblasts-FLPe NLS2 at a ratio of 50:50. After the cell cultures had become nearly confluent, they were either given fresh growth medium or exposed to differentiation medium. This was followed by the periodic collection of culture fluid for luciferase measurements using two different approaches. In one experiment, the culture medium was left on the cells for different time periods (i.e. from 0-24, 0-36, 0-48, 0-60, 0-72, 0-84, 0-96, 0-108 and 0-120 h) before being harvested for luminometry (''cumulative assay''; Fig. 8 ). In the other experiment, the culture fluid was refreshed every 24 h and the amount of biologically active luciferase that had been secreted between 0-24, 24-48, 48-72, 72-96 and 96-120 h after the start of the differentiation process was determined (''kinetics assay''; Fig. 9 ). As shown in Fig. 8A , following an initial slow increase, the luciferase activity in the culture medium of the serum-deprived co-cultures rose sharply .PurR/LV.GS.GpLuc.v1-based cell fusion assay system. (A): Luminometric analysis of culture medium of myoblasts GS.GLuc co-cultured with myoblasts-FLPe NLS+ (+) or with myoblasts-FLPe NLS2 (2) at the indicated ratios. At 72 h after cell seeding, the culture fluid in each well was replaced by fresh culture medium with (growth conditions, no differentiation) or without (differentiation conditions) serum. Nighty-six h later the culture media were collected and subjected to luciferase activity measurements. Bars represent mean 6 standard error of the mean (n = 3). (B): Fold change in luciferase activity calculated on the basis of the data presented in (A). For each culture composition the average light production under growth conditions was the denominator and the mean of the RLUs produced under differentiation conditions was the numerator. RLUs, relative light units; MBs (Fig. 5A ). These findings were corroborated by the data derived from the ''kinetics assay'' (Fig. 9) .
. On the basis of the previous results, another experiment was carried out in which we directly compared the performance of (Fig. 10A) and to higher signal-to-noise ratios ( Fig. 10B ). In accordance with the experiment presented in Fig. 7 , the co-cultures consisting of 75% myoblasts GS.GLuc and 25% myoblasts-FLPe yielded the highest signals both in absolute (Fig. 10A) and relative (Fig. 10B) terms. Also in line with the previous experiments was the finding that most GpLuc accumulation takes place between 96 and 120 h after serum removal. . (A): Luminometric analysis of culture medium of co-cultures of 50% myoblasts GS.GLuc and 50% myoblastsFLPe NLS+ (+) or 50% myoblasts-FLPe NLS2 (2) . At 72 h after cell seeding, the culture fluid was replaced by fresh culture medium with (growth conditions, no differentiation) or without (differentiation conditions) serum, which was left on the cells for the indicated 24-h time intervals. Bars represent mean 6 standard error of the mean (n = 3). (B): Fold change in luciferase activity calculated on the basis of the data presented in (A). For each sampling time the average light production under growth conditions was the denominator and the mean of the RLUs produced under differentiation conditions was the numerator. RLUs, relative light units; NLS, nuclear localization signal. doi:10.1371/journal.pone.0102433.g009 GS.GLuc and myoblasts-FLPe were seeded in different ratios (i.e. 95:5%, 75:25%, 25:75% and 5:95%). At 72 h after cell seeding, the culture fluid was replaced by fresh culture medium with (growth conditions, no differentiation) or without (differentiation conditions) serum. Fourthy-eight h later the culture medium was refreshed once again. Twenty-four h later the culture fluid was harvested for luciferase activity measurement and replaced by the same volume of fresh culture medium. This procedure was repeated every 24 h until 120 h after the first medium change. Bars represent mean 6 standard error of the mean (n = 3). (B): Fold change in luciferase activity calculated on the basis of the data presented in (A). For each experimental condition the average light production under growth conditions was the denominator and the mean of the RLUs produced under differentiation conditions was the numerator. RLUs, relative light units; MBs GS.GLuc or myoblasts GS.GLuc+ with myoblasts-FLPe NLS+ at different times after culture initiation. Cells were seeded in different ratios (i.e. 100:0%, 90:10% and 75:25%). At 72 h after cell seeding the culture fluid was replaced by fresh culture medium with (growth conditions, no differentiation) or without (differentiation conditions) serum. Ninety-six h and 120 h later culture medium collected for luciferase activity measurement. Bars represent mean 6 standard error of the mean (n = 3). (B): Fold change in luciferase activity calculated on the basis of the data presented in (A). For each experimental condition the average light production under growth conditions was the denominator and the mean of the RLUs produced under differentiation conditions was the numerator. RLUs, relative light units; G1, LV.GS.GpLuc.v1-based cell fusion assay; G6, LV.GS.GpLuc.v6-based cell fusion assay; MBs Fig. 11 with 12) . Considering that the sequences in between the mMT1 pA and the Luc start codon in LV.GS.PpLuc and LV.GS.GpLuc.v1 are nearly identical this may suggest that the GpLuc-coding sequence itself is the source of the relatively high luciferase activity detected in medium of differentiating LV.GS.GpLuc monocultures. If so, the problem could be overcome by switching to another secretory luciferase (e.g. Vargula hilgendorfii luciferase [26] , Lucia luciferase (InvivoGen Europe, Toulouse, France) or secretory NanoLuc [27] ). Also the fact that GpLuc is a secretory protein with a long half-life (66 days in culture medium) [28] while Ppluc has a relatively short half-life (62 hours in cells) [29] may contribute to the higher background signals associated with LV.GS.GpLuc.v1 and LV.GS.GpLuc.v6 than with LV.GS.PpLuc.
Taken together, in this paper a new assay to quantify (the progression of) cell-to-cell fusion activity is described. Due to its nondestructive nature allowing repeated sampling of the same specimen, this assay will be an attractive alternative to existing quantitative cell fusion assays based on (i) light microscopic assessment of multinucleation, (ii) fluorescence dequenching, (iii) fluorescence resonance energy transfer, (iv) biochemical complementation or (v) activation of reporter genes different from GpLuc including LacZ and PpLuc [3] . Other advantages of the LV.FLPe NLS+/2 .PurR/LV.GS.GpLuc-based cell fusion assay include the simplicity and speed of the analytical procedures and the ability to combine it with (immuno)cytology, real-time microscopy, cell function assays and other methods to study cell behavior.
The sensitivity of the current assay could be improved by changing the human glyceraldehyde 3-phosphate dehydrogenase (hGAPDH) gene promoter driving GpLuc expression for a promoter with higher activity in the cell type(s) under investigation. In addition, the sequences interspersed between the 39 long terminal repeat (LTR) and the GpLuc initiation codon of LV.GS.GpLuc.v6 may be further optimized to minimize leaky GpLuc expression.
